USANA Health Sciences Return on Tangible Equity 2012-2026 | USNA

Current and historical return on tangible equity values for USANA Health Sciences (USNA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
USANA Health Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2026-06-30 $-0.02B $0.27B -8.16%
2026-03-31 $0.01B $0.26B 3.50%
2025-12-31 $0.01B $0.25B 4.04%
2025-09-30 $0.02B $0.24B 6.64%
2025-06-30 $0.03B $0.30B 11.29%
2025-03-31 $0.03B $0.36B 9.52%
2024-12-31 $0.04B $0.41B 10.22%
2024-09-30 $0.06B $0.47B 11.84%
2024-06-30 $0.06B $0.45B 12.26%
2024-03-31 $0.06B $0.44B 14.17%
2023-12-31 $0.06B $0.43B 14.81%
2023-09-30 $0.06B $0.41B 14.42%
2023-06-30 $0.06B $0.39B 16.00%
2023-03-31 $0.07B $0.38B 17.28%
2022-12-31 $0.07B $0.36B 19.15%
2022-09-30 $0.08B $0.35B 21.67%
2022-06-30 $0.09B $0.35B 25.29%
2022-03-31 $0.11B $0.35B 30.33%
2021-12-31 $0.12B $0.36B 32.58%
2021-09-30 $0.14B $0.37B 37.01%
2021-06-30 $0.14B $0.37B 38.33%
2021-03-31 $0.13B $0.35B 37.30%
2020-12-31 $0.13B $0.33B 38.44%
2020-09-30 $0.12B $0.31B 38.27%
2020-06-30 $0.11B $0.29B 38.29%
2020-03-31 $0.10B $0.30B 34.89%
2019-12-31 $0.10B $0.31B 31.97%
2019-09-30 $0.10B $0.32B 31.34%
2019-06-30 $0.11B $0.35B 30.68%
2019-03-31 $0.12B $0.36B 33.38%
2018-12-31 $0.13B $0.36B 34.64%
2018-09-30 $0.09B $0.36B 24.74%
2018-06-30 $0.08B $0.34B 24.05%
2018-03-31 $0.07B $0.33B 21.52%
2017-12-31 $0.06B $0.31B 19.73%
2017-09-30 $0.09B $0.31B 29.51%
2017-06-30 $0.10B $0.29B 33.02%
2017-03-31 $0.10B $0.26B 37.68%
2016-12-31 $0.10B $0.23B 42.69%
2016-09-30 $0.10B $0.22B 45.95%
2016-06-30 $0.10B $0.22B 44.04%
2016-03-31 $0.10B $0.22B 43.30%
2015-12-31 $0.10B $0.23B 42.18%
2015-09-30 $0.09B $0.21B 43.45%
2015-06-30 $0.09B $0.18B 46.51%
2015-03-31 $0.08B $0.18B 45.14%
2014-12-31 $0.08B $0.18B 41.82%
2014-09-30 $0.08B $0.19B 39.68%
2014-06-30 $0.07B $0.20B 36.78%
2014-03-31 $0.08B $0.19B 41.43%
2013-12-31 $0.08B $0.17B 47.88%
2013-09-30 $0.08B $0.15B 52.56%
2013-06-30 $0.08B $0.14B 56.51%
2013-03-31 $0.07B $0.13B 54.37%
2012-12-31 $0.07B $0.13B 50.97%
2012-09-30 $0.06B $0.13B 48.22%
2012-06-30 $0.06B $0.12B 47.86%
2012-03-31 $0.05B $0.11B 48.51%
2011-12-31 $0.05B $0.10B 50.00%
2011-09-30 $0.05B $0.09B 52.41%
2011-06-30 $0.05B $0.09B 57.64%
2011-03-31 $0.05B $0.09B 54.18%
2010-12-31 $0.05B $0.08B 55.09%
2010-09-30 $0.04B $0.08B 55.87%
2010-06-30 $0.04B $0.08B 52.00%
2010-03-31 $0.04B $0.06B 58.27%
2009-12-31 $0.03B $0.05B 65.38%
2009-09-30 $0.03B $0.04B 67.88%
2009-06-30 $0.03B $0.04B 76.71%
2009-03-31 $0.03B $0.04B 74.84%
2008-12-31 $0.03B $0.04B 70.73%
2008-09-30 $0.04B $0.04B 87.27%
2008-06-30 $0.04B $0.04B 106.85%
2008-03-31 $0.04B $0.03B 158.42%
2007-12-31 $0.05B $0.03B 146.34%
2007-09-30 $0.04B $0.04B 116.56%
2007-06-30 $0.04B $0.05B 96.63%
2007-03-31 $0.04B $0.05B 83.58%
2006-12-31 $0.04B $0.05B 85.56%
2006-09-30 $0.04B $0.04B 93.02%
2006-06-30 $0.04B $0.05B 85.56%
2006-03-31 $0.04B $0.05B 79.21%
2005-12-31 $0.04B $0.05B 76.10%
2005-09-30 $0.04B $0.05B 73.43%
2005-06-30 $0.04B $0.05B 76.60%
2005-03-31 $0.03B $0.05B 74.16%
2004-12-31 $0.03B $0.04B 75.00%
2004-09-30 $0.03B $0.04B 70.89%
2004-06-30 $0.03B $0.04B 72.22%
2004-03-31 $0.02B $0.03B 67.65%
2003-12-31 $0.02B $0.03B 68.29%
2003-09-30 $0.02B $0.03B 67.33%
2003-06-30 $0.01B $0.02B 57.78%
2003-03-31 $0.01B $0.02B 57.89%
2002-12-31 $0.01B $0.02B 47.06%
2002-09-30 $0.01B $0.02B 36.92%
2002-06-30 $0.01B $0.02B 32.26%
2002-03-31 $0.00B $0.02B 20.34%
2001-12-31 $0.00B $0.01B 14.29%
2001-09-30 $0.00B $0.01B 14.81%
2001-06-30 $0.00B $0.01B 7.69%
2001-03-31 $0.00B $0.01B 8.00%
2000-12-31 $0.00B $0.01B 16.33%
2000-09-30 $0.00B $0.01B 24.49%
2000-06-30 $0.00B $0.01B 16.67%
2000-03-31 $0.00B $0.02B 23.88%
1999-12-31 $0.01B $0.02B 22.73%
1999-09-30 $0.01B $0.03B 22.64%
1999-06-30 $0.01B $0.03B 32.79%
1999-03-31 $0.01B $0.03B 34.78%
1998-12-31 $0.01B $0.03B 38.83%
1998-09-30 $0.01B $0.02B 39.13%
1998-06-30 $0.01B $0.02B 39.02%
1998-03-31 $0.01B $0.02B 43.84%
1997-12-31 $0.01B $0.02B 42.42%
1997-09-30 $0.01B $0.02B 41.38%
1997-06-30 $0.01B $0.01B 38.46%
1997-03-31 $0.00B $0.01B 34.78%
1996-12-31 $0.00B $0.01B 40.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.275B $0.925B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00